Osmia bicornis bicornis chromosome 15, iOsmBic2.1, whole genome shotgun sequence.
Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta; Pterygota; Neoptera; Endopterygota; Hymenoptera; Apocrita; Aculeata; Apoidea; Megachilidae; Megachilinae; Osmia.
REFSEQ INFORMATION: The reference sequence is identical to\nOU015518.1.\nAssembly name: iOsmBic2.1\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the WELLCOME SANGER INSTITUTE on\n2021/05/17. The original whole-genome shotgun project has the\naccession CAJRAL000000000.1.\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Osmia bicornis bicornis Annotation\n Release 101\nAnnotation Version :: 101\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
COORDINATES: polyA evidence [ECO:0006239]
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: zinc finger protein 420-like
putative uncharacterized protein DDB_G0268364
uncharacterized LOC123988508, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized protein LOC123988508 isoform X2
uncharacterized LOC123988508, transcript variant X1
uncharacterized protein LOC123988508 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC114876038, transcript variant X1
uncharacterized LOC114876038, transcript variant X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 5 bases in 4 codons; deleted 5 bases in 4 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 5 bases in 4 codons; deleted 5 bases in 4 codons; substituted 3 bases at 3 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: enolase-phosphatase E1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; deleted 2 bases in 2 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; deleted 2 bases in 2 codons; substituted 2 bases at 2 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: zinc finger protein 135-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
phosphofurin acidic cluster sorting protein 2, transcript variant X3
phosphofurin acidic cluster sorting protein 2, transcript variant X6
phosphofurin acidic cluster sorting protein 2 isoform X3
phosphofurin acidic cluster sorting protein 2 isoform X6
phosphofurin acidic cluster sorting protein 2, transcript variant X1
phosphofurin acidic cluster sorting protein 2, transcript variant X2
phosphofurin acidic cluster sorting protein 2, transcript variant X8
phosphofurin acidic cluster sorting protein 2, transcript variant X4
phosphofurin acidic cluster sorting protein 2, transcript variant X7
phosphofurin acidic cluster sorting protein 2 isoform X7
phosphofurin acidic cluster sorting protein 2 isoform X1
phosphofurin acidic cluster sorting protein 2 isoform X2
phosphofurin acidic cluster sorting protein 2 isoform X8
phosphofurin acidic cluster sorting protein 2 isoform X4
phosphofurin acidic cluster sorting protein 2, transcript variant X5
phosphofurin acidic cluster sorting protein 2 isoform X5
ejaculatory bulb-specific protein 3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
transcriptional adapter 2B, transcript variant X2
transcriptional adapter 2B, transcript variant X1
transcriptional adapter 2B, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
MATH and LRR domain-containing protein PFE0570w, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
MATH and LRR domain-containing protein PFE0570w, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
MATH and LRR domain-containing protein PFE0570w, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
MATH and LRR domain-containing protein PFE0570w, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
MATH and LRR domain-containing protein PFE0570w isoform X3
uncharacterized protein LOC114876027 isoform X1
MATH and LRR domain-containing protein PFE0570w isoform X2
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA serine (anticodon CGA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized LOC114876023, transcript variant X2
uncharacterized LOC114876023, transcript variant X1
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00619
low-density lipoprotein receptor-like, transcript variant X4
low-density lipoprotein receptor-like, transcript variant X1
low-density lipoprotein receptor-like, transcript variant X8
low-density lipoprotein receptor-like, transcript variant X7
low-density lipoprotein receptor-like, transcript variant X2
low-density lipoprotein receptor-like, transcript variant X5
low-density lipoprotein receptor-like, transcript variant X3
low-density lipoprotein receptor-like, transcript variant X6
low-density lipoprotein receptor-like isoform X8
low-density lipoprotein receptor-like isoform X7
low-density lipoprotein receptor-like isoform X4
very low-density lipoprotein receptor-like isoform X1
very low-density lipoprotein receptor-like isoform X2
very low-density lipoprotein receptor-like isoform X5
very low-density lipoprotein receptor-like isoform X3
low-density lipoprotein receptor-like isoform X6
uncharacterized LOC114876026, transcript variant X3
uncharacterized LOC114876026, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC114876026, transcript variant X6
uncharacterized LOC114876026, transcript variant X2
uncharacterized LOC114876026, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC114876026, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
probable cytosolic Fe-S cluster assembly factor AGAP009023, transcript variant X2
probable cytosolic Fe-S cluster assembly factor AGAP009023, transcript variant X4
probable cytosolic Fe-S cluster assembly factor AGAP009023, transcript variant X1
probable cytosolic Fe-S cluster assembly factor AGAP009023, transcript variant X3
probable cytosolic Fe-S cluster assembly factor AGAP009023 isoform X2
probable cytosolic Fe-S cluster assembly factor AGAP009023 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
trafficking protein particle complex subunit 8
uncharacterized LOC114876017, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
uncharacterized LOC114876017, transcript variant X1
uncharacterized protein LOC114876017 isoform X1
uncharacterized protein LOC114876017 isoform X2
uncharacterized protein LOC114876018 isoform X2
kynurenine/alpha-aminoadipate aminotransferase, mitochondrial-like
uncharacterized LOC114876010, transcript variant X7
uncharacterized LOC114876010, transcript variant X6
uncharacterized LOC114876010, transcript variant X5
uncharacterized LOC114876010, transcript variant X3
uncharacterized LOC114876010, transcript variant X4
uncharacterized LOC114876010, transcript variant X2
uncharacterized LOC114876010, transcript variant X1
uncharacterized LOC114876010, transcript variant X8
recQ-mediated genome instability protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
2-methoxy-6-polyprenyl-1,4-benzoquinol methylase, mitochondrial, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
2-methoxy-6-polyprenyl-1,4-benzoquinol methylase, mitochondrial, transcript variant X1
2-methoxy-6-polyprenyl-1,4-benzoquinol methylase, mitochondrial
transmembrane ascorbate-dependent reductase CYB561
chitinase-3-like protein 2, transcript variant X1
chitinase-3-like protein 2, transcript variant X2
chitinase-3-like protein 2, transcript variant X3
eukaryotic translation initiation factor 3 subunit J
DNA repair protein RAD52 homolog, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
DNA repair protein RAD52 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
DNA repair protein RAD52 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
DNA repair protein RAD52 homolog isoform X3
DNA repair protein RAD52 homolog isoform X1
DNA repair protein RAD52 homolog isoform X2
probable protein arginine N-methyltransferase 6.1
tryptophan--tRNA ligase, cytoplasmic, transcript variant X1
tryptophan--tRNA ligase, cytoplasmic, transcript variant X2
protein phosphatase 1B-like, transcript variant X4
protein phosphatase 1B-like, transcript variant X3
protein phosphatase 1B-like, transcript variant X1
protein phosphatase 1B-like, transcript variant X2
beclin 1-associated autophagy-related key regulator, transcript variant X2
beclin 1-associated autophagy-related key regulator, transcript variant X1
beclin 1-associated autophagy-related key regulator isoform X2
beclin 1-associated autophagy-related key regulator isoform X1
gamma-tubulin complex component 4, transcript variant X1
gamma-tubulin complex component 4, transcript variant X2
vesicle transport protein USE1, transcript variant X4
vesicle transport protein USE1, transcript variant X5
vesicle transport protein USE1, transcript variant X3
vesicle transport protein USE1, transcript variant X2
vesicle transport protein USE1, transcript variant X7
vesicle transport protein USE1, transcript variant X1
vesicle transport protein USE1, transcript variant X6
vesicle transport protein USE1 isoform X1
vesicle transport protein USE1 isoform X2
GTP-binding protein 1, transcript variant X1
GTP-binding protein 1, transcript variant X2
GTP-binding protein 1, transcript variant X3
uncharacterized LOC114872913, transcript variant X1
uncharacterized LOC114872913, transcript variant X2
serine/arginine repetitive matrix protein 2, transcript variant X1
serine/arginine repetitive matrix protein 2, transcript variant X2
serine/arginine repetitive matrix protein 2, transcript variant X3
serine/arginine repetitive matrix protein 2, transcript variant X4
serine/arginine repetitive matrix protein 2 isoform X1
uncharacterized protein LOC114872901 isoform X2
uncharacterized protein LOC114872901 isoform X3
uncharacterized protein LOC114872901 isoform X4
CCA tRNA nucleotidyltransferase 1, mitochondrial, transcript variant X1
CCA tRNA nucleotidyltransferase 1, mitochondrial, transcript variant X2
CCA tRNA nucleotidyltransferase 1, mitochondrial
transcription initiation factor IIA subunit 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
SR-related and CTD-associated factor 4, transcript variant X2
SR-related and CTD-associated factor 4, transcript variant X1
SR-related and CTD-associated factor 4, transcript variant X3
SR-related and CTD-associated factor 4 isoform X1
SR-related and CTD-associated factor 4 isoform X2
proteasome assembly chaperone 2-like, transcript variant X3
proteasome assembly chaperone 2-like, transcript variant X2
proteasome assembly chaperone 2-like, transcript variant X1
translocon-associated protein subunit delta
pleckstrin homology domain-containing family J member 1-like
E3 ubiquitin ligase Rnf157, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
E3 ubiquitin ligase Rnf157, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
E3 ubiquitin ligase Rnf157, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
E3 ubiquitin ligase Rnf157, transcript variant X4
mediator of RNA polymerase II transcription subunit 9
mitogen-activated protein kinase kinase kinase 7
bestrophin-4-like, transcript variant X8
bestrophin-4-like, transcript variant X7
bestrophin-4-like, transcript variant X6
bestrophin-4-like, transcript variant X5
bestrophin-4-like, transcript variant X4
bestrophin-4-like, transcript variant X3
bestrophin-4-like, transcript variant X2
bestrophin-4-like, transcript variant X1
26S proteasome non-ATPase regulatory subunit 9
tetratricopeptide repeat protein 30A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
tetratricopeptide repeat protein 30A, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
tetratricopeptide repeat protein 30A, transcript variant X4
tetratricopeptide repeat protein 30A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
tetratricopeptide repeat protein 30A isoform X1
tetratricopeptide repeat protein 30A isoform X2
DNA polymerase epsilon subunit 2, transcript variant X2
DNA polymerase epsilon subunit 2, transcript variant X1
DNA polymerase epsilon subunit 2 isoform X2
DNA polymerase epsilon subunit 2 isoform X1
uncharacterized LOC114872949, transcript variant X2
uncharacterized LOC114872949, transcript variant X4
uncharacterized LOC114872949, transcript variant X3
uncharacterized LOC114872949, transcript variant X5
uncharacterized LOC114872949, transcript variant X1
uncharacterized protein LOC114872949 isoform X2
uncharacterized protein LOC114872949 isoform X1
U3 small nucleolar RNA-associated protein 25 homolog
uncharacterized LOC114872853, transcript variant X1
uncharacterized protein LOC114872853 isoform X1
uncharacterized LOC114872853, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
uncharacterized protein LOC114872853 isoform X2
neurofilament medium polypeptide-like, transcript variant X3
neurofilament medium polypeptide-like, transcript variant X1
neurofilament medium polypeptide-like, transcript variant X2
neurofilament medium polypeptide-like isoform X3
ataxin-7-like protein 3, transcript variant X1
ataxin-7-like protein 3, transcript variant X2
replication stress response regulator SDE2
uncharacterized LOC114872859, transcript variant X2
uncharacterized LOC114872859, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC114872859, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
uncharacterized protein LOC114872859 isoform X2
uncharacterized protein LOC114872859 isoform X1
melanization protease 1, transcript variant X1
melanization protease 1, transcript variant X2
HSPB1-associated protein 1, transcript variant X1
HSPB1-associated protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
mitochondrial intermembrane space import and assembly protein 40-B
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: uncharacterized protein LOC114872906
RING-type E3 ubiquitin-protein ligase PPIL2
ankyrin repeat and zinc finger domain-containing protein 1-like
receptor-type guanylate cyclase daf-11, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
receptor-type guanylate cyclase daf-11, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
receptor-type guanylate cyclase daf-11, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
receptor-type guanylate cyclase daf-11, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
receptor-type guanylate cyclase daf-11 isoform X1
receptor-type guanylate cyclase daf-11 isoform X2
receptor-type guanylate cyclase daf-11 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
zinc finger protein 571, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
zinc finger protein 571, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
zinc finger protein 571, transcript variant X5
zinc finger protein 571, transcript variant X2
zinc finger protein 571, transcript variant X1
uncharacterized LOC114872844, transcript variant X2
uncharacterized LOC114872844, transcript variant X1
uncharacterized protein LOC114872844 isoform X1
uncharacterized protein LOC114872844 isoform X2
ARF GTPase-activating protein GIT1, transcript variant X4
ARF GTPase-activating protein GIT1, transcript variant X3
ARF GTPase-activating protein GIT1, transcript variant X2
ARF GTPase-activating protein GIT1, transcript variant X1
ARF GTPase-activating protein GIT1 isoform X1
ARF GTPase-activating protein GIT1 isoform X2
ARF GTPase-activating protein GIT1, transcript variant X5
ARF GTPase-activating protein GIT1 isoform X3
synaptosomal-associated protein 25, transcript variant X5
synaptosomal-associated protein 25, transcript variant X2
synaptosomal-associated protein 25, transcript variant X1
synaptosomal-associated protein 25, transcript variant X3
synaptosomal-associated protein 25, transcript variant X4
synaptosomal-associated protein 25, transcript variant X6
synaptosomal-associated protein 25 isoform X2
synaptosomal-associated protein 25 isoform X1
synaptosomal-associated protein 25 isoform X3
synaptosomal-associated protein 25 isoform X4
uncharacterized LOC114872842, transcript variant X3
uncharacterized LOC114872842, transcript variant X2
uncharacterized LOC114872842, transcript variant X1
uncharacterized LOC114872842, transcript variant X4
uncharacterized protein LOC114872842 isoform X2
uncharacterized protein LOC114872842 isoform X1
uncharacterized protein LOC114872842 isoform X3
uncharacterized protein LOC114872842 isoform X4
uncharacterized LOC114872942, transcript variant X1
uncharacterized LOC114872942, transcript variant X2
uncharacterized LOC114872942, transcript variant X3
uncharacterized LOC114872927, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized protein LOC114872927 isoform X1
uncharacterized LOC114872927, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized protein LOC114872927 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC114872926, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
uncharacterized LOC114872926, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
uncharacterized protein LOC114872926 isoform X2
uncharacterized protein LOC114872926 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
uncharacterized LOC114872939, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized LOC114872939, transcript variant X1
solute carrier family 35 member F5, transcript variant X1
solute carrier family 35 member F5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: uncharacterized protein LOC114872924
inosine-5'-monophosphate dehydrogenase 1b
eukaryotic translation elongation factor 1 epsilon-1, transcript variant X2
eukaryotic translation elongation factor 1 epsilon-1, transcript variant X1
eukaryotic translation elongation factor 1 epsilon-1 isoform X1
eukaryotic translation elongation factor 1 epsilon-1 isoform X2
uncharacterized LOC114872923, transcript variant X2
uncharacterized LOC114872923, transcript variant X1
outer dynein arm-docking complex subunit 4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
outer dynein arm-docking complex subunit 4
solute carrier family 52, riboflavin transporter, member 3-A-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
solute carrier family 52, riboflavin transporter, member 3-A-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
solute carrier family 52, riboflavin transporter, member 3-A-like, transcript variant X1
solute carrier family 52, riboflavin transporter, member 3-A-like
solute carrier family 52, riboflavin transporter, member 3-B-like
F-box/WD repeat-containing protein 9-like, transcript variant X2
F-box/WD repeat-containing protein 9-like, transcript variant X1
F-box/WD repeat-containing protein 9-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 84% coverage of the annotated genomic feature by RNAseq alignments
zinc finger and BTB domain-containing protein 17-like
protein rolling stone-like, transcript variant X2
protein rolling stone-like, transcript variant X1
protein rolling stone-like, transcript variant X6
protein rolling stone-like, transcript variant X4
protein rolling stone-like, transcript variant X5
protein rolling stone-like, transcript variant X3
voltage-dependent calcium channel subunit alpha-2/delta-3, transcript variant X1
voltage-dependent calcium channel subunit alpha-2/delta-3, transcript variant X2
voltage-dependent calcium channel subunit alpha-2/delta-3 isoform X1
voltage-dependent calcium channel subunit alpha-2/delta-3 isoform X2
voltage-dependent calcium channel subunit alpha-2/delta-3, transcript variant X5
voltage-dependent calcium channel subunit alpha-2/delta-3, transcript variant X3
voltage-dependent calcium channel subunit alpha-2/delta-3 isoform X3
voltage-dependent calcium channel subunit alpha-2/delta-3, transcript variant X4
voltage-dependent calcium channel subunit alpha-2/delta-3, transcript variant X6
voltage-dependent calcium channel subunit alpha-2/delta-3 isoform X4
voltage-dependent calcium channel subunit alpha-2/delta-3 isoform X5
scm-like with four MBT domains protein 1, transcript variant X3
scm-like with four MBT domains protein 1, transcript variant X1
scm-like with four MBT domains protein 1, transcript variant X7
scm-like with four MBT domains protein 1, transcript variant X6
scm-like with four MBT domains protein 1, transcript variant X4
scm-like with four MBT domains protein 1, transcript variant X2
scm-like with four MBT domains protein 1, transcript variant X5
scm-like with four MBT domains protein 1 isoform X1
scm-like with four MBT domains protein 1 isoform X3
scm-like with four MBT domains protein 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
5-demethoxyubiquinone hydroxylase, mitochondrial, transcript variant X1
5-demethoxyubiquinone hydroxylase, mitochondrial, transcript variant X3
5-demethoxyubiquinone hydroxylase, mitochondrial, transcript variant X2
5-demethoxyubiquinone hydroxylase, mitochondrial, transcript variant X5
5-demethoxyubiquinone hydroxylase, mitochondrial, transcript variant X4
5-demethoxyubiquinone hydroxylase, mitochondrial isoform X1
5-demethoxyubiquinone hydroxylase, mitochondrial isoform X2
DNA-binding protein P3A2, transcript variant X2
DNA-binding protein P3A2, transcript variant X4
DNA-binding protein P3A2, transcript variant X1
DNA-binding protein P3A2, transcript variant X6
DNA-binding protein P3A2, transcript variant X7
DNA-binding protein P3A2, transcript variant X3
DNA-binding protein P3A2, transcript variant X5
cytochrome c oxidase subunit 5A, mitochondrial
SPRY domain-containing SOCS box protein 3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
protein yippee-like 1, transcript variant X2
protein yippee-like 1, transcript variant X3
protein yippee-like 1, transcript variant X1
FGGY carbohydrate kinase domain-containing protein, transcript variant X1
FGGY carbohydrate kinase domain-containing protein, transcript variant X2
FGGY carbohydrate kinase domain-containing protein
uncharacterized LOC114872879, transcript variant X5
uncharacterized LOC114872879, transcript variant X4
uncharacterized LOC114872879, transcript variant X1
uncharacterized LOC114872879, transcript variant X3
uncharacterized LOC114872879, transcript variant X2
uncharacterized protein LOC114872879 isoform X1
uncharacterized protein LOC114872879 isoform X2
uncharacterized protein LOC114872879 isoform X3
uncharacterized protein LOC114872879 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
A-kinase anchor protein 10, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
luciferin 4-monooxygenase, transcript variant X1
luciferin 4-monooxygenase, transcript variant X2
3'(2'),5'-bisphosphate nucleotidase 1, transcript variant X2
3'(2'),5'-bisphosphate nucleotidase 1, transcript variant X1
dimethyladenosine transferase 2, mitochondrial, transcript variant X2
dimethyladenosine transferase 2, mitochondrial, transcript variant X1
dimethyladenosine transferase 2, mitochondrial
dynein regulatory complex subunit 7, transcript variant X1
dynein regulatory complex subunit 7, transcript variant X3
dynein regulatory complex subunit 7, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
dynein regulatory complex subunit 7, transcript variant X5
dynein regulatory complex subunit 7, transcript variant X7
dynein regulatory complex subunit 7, transcript variant X11
dynein regulatory complex subunit 7 isoform X1
dynein regulatory complex subunit 7 isoform X2
dynein regulatory complex subunit 7 isoform X4
dynein regulatory complex subunit 7 isoform X6
dynein regulatory complex subunit 7 isoform X9
dynein regulatory complex subunit 7, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
dynein regulatory complex subunit 7 isoform X5
dynein regulatory complex subunit 7, transcript variant X4
dynein regulatory complex subunit 7 isoform X3
dynein regulatory complex subunit 7, transcript variant X10
dynein regulatory complex subunit 7, transcript variant X8
dynein regulatory complex subunit 7 isoform X7
dynein regulatory complex subunit 7, transcript variant X9
dynein regulatory complex subunit 7 isoform X8
FERM domain-containing protein 8, transcript variant X2
FERM domain-containing protein 8, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
FERM domain-containing protein 8 isoform X2
FERM domain-containing protein 8 isoform X1
metastasis-associated protein MTA3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
metastasis-associated protein MTA3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
metastasis-associated protein MTA3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
metastasis-associated protein MTA3 isoform X1
metastasis-associated protein MTA3 isoform X2
metastasis-associated protein MTA3 isoform X3
GPI ethanolamine phosphate transferase 1, transcript variant X2
GPI ethanolamine phosphate transferase 1, transcript variant X1
GPI ethanolamine phosphate transferase 1 isoform X2
GPI ethanolamine phosphate transferase 1 isoform X1
putative OPA3-like protein CG13603, transcript variant X2
putative OPA3-like protein CG13603, transcript variant X1
centrosomal protein CCDC61-like, transcript variant X1
centrosomal protein CCDC61-like, transcript variant X3
centrosomal protein CCDC61-like, transcript variant X2
probable glucosamine 6-phosphate N-acetyltransferase
uncharacterized LOC114872916, transcript variant X1
uncharacterized LOC114872916, transcript variant X2
bromodomain adjacent to zinc finger domain protein 1A, transcript variant X4
bromodomain adjacent to zinc finger domain protein 1A, transcript variant X3
bromodomain adjacent to zinc finger domain protein 1A, transcript variant X2
bromodomain adjacent to zinc finger domain protein 1A, transcript variant X1
bromodomain adjacent to zinc finger domain protein 1A isoform X3
bromodomain adjacent to zinc finger domain protein 1A isoform X2
bromodomain adjacent to zinc finger domain protein 1A isoform X1
probable DNA-directed RNA polymerase III subunit RPC6
dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
aldo-keto reductase family 1 member A1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
aldo-keto reductase family 1 member A1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
aldo-keto reductase family 1 member A1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
aldo-keto reductase family 1 member A1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
1,5-anhydro-D-fructose reductase-like isoform X1
1,5-anhydro-D-fructose reductase-like isoform X2
aldo-keto reductase family 1 member A1-like isoform X3
uncharacterized LOC114872977, transcript variant X1
uncharacterized LOC114872977, transcript variant X2
uncharacterized LOC114872977, transcript variant X3
uncharacterized protein LOC114872977 isoform X1
uncharacterized protein LOC114872977 isoform X2
uncharacterized protein LOC114872977 isoform X3
E3 ubiquitin-protein ligase synoviolin A, transcript variant X2
E3 ubiquitin-protein ligase synoviolin A, transcript variant X1
E3 ubiquitin-protein ligase synoviolin A isoform X2
E3 ubiquitin-protein ligase synoviolin A isoform X1
serine/threonine-protein phosphatase 4 regulatory subunit 3, transcript variant X2
serine/threonine-protein phosphatase 4 regulatory subunit 3, transcript variant X1
serine/threonine-protein phosphatase 4 regulatory subunit 3 isoform X1
serine/threonine-protein phosphatase 4 regulatory subunit 3 isoform X2
cilia- and flagella-associated protein 36
LHFPL tetraspan subfamily member 5 protein, transcript variant X1
LHFPL tetraspan subfamily member 5 protein, transcript variant X2
LHFPL tetraspan subfamily member 5 protein, transcript variant X3
LHFPL tetraspan subfamily member 5 protein
pre-mRNA-splicing factor 38, transcript variant X2
pre-mRNA-splicing factor 38, transcript variant X1
uncharacterized LOC114881700, transcript variant X3
uncharacterized LOC114881700, transcript variant X2
uncharacterized LOC114881700, transcript variant X1
uncharacterized LOC114881700, transcript variant X5
uncharacterized LOC114881700, transcript variant X4
uncharacterized protein LOC114881700 isoform X3
uncharacterized protein LOC114881700 isoform X2
uncharacterized protein LOC114881700 isoform X5
uncharacterized protein LOC114881700 isoform X1
uncharacterized protein LOC114881700 isoform X4
replication protein A 70 kDa DNA-binding subunit
dnaJ homolog subfamily C member 10-like, transcript variant X1
dnaJ homolog subfamily C member 10-like isoform X1
dnaJ homolog subfamily C member 10-like, transcript variant X2
dnaJ homolog subfamily C member 10-like isoform X2
EH domain-containing protein 3, transcript variant X1
EH domain-containing protein 3, transcript variant X2
EH domain-containing protein 3 isoform X1
EH domain-containing protein 1 isoform X2
diuretic hormone class 2, transcript variant X1
diuretic hormone class 2, transcript variant X2
diuretic hormone class 2, transcript variant X5
diuretic hormone class 2, transcript variant X6
diuretic hormone class 2, transcript variant X3
diuretic hormone class 2, transcript variant X4
protein adenylyltransferase Fic, transcript variant X1
protein adenylyltransferase Fic, transcript variant X2
protein adenylyltransferase Fic isoform X1
protein adenylyltransferase Fic isoform X2
kinesin-like protein Klp10A, transcript variant X3
kinesin-like protein Klp10A, transcript variant X4
kinesin-like protein Klp10A, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
kinesin-like protein Klp10A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
kinesin-like protein Klp10A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
mutS protein homolog 5-like, transcript variant X2
mutS protein homolog 5-like, transcript variant X1
uncharacterized LOC123987643, transcript variant X5
uncharacterized LOC123987643, transcript variant X6
uncharacterized LOC123987643, transcript variant X4
uncharacterized LOC123987643, transcript variant X2
uncharacterized LOC123987643, transcript variant X1
uncharacterized protein LOC123987643 isoform X2
uncharacterized protein LOC123987643 isoform X1
uncharacterized protein LOC123987643 isoform X4
uncharacterized LOC123987643, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized protein LOC123987643 isoform X3
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5
40S ribosomal protein S5, transcript variant X2
40S ribosomal protein S5, transcript variant X1
40S ribosomal protein S5, transcript variant X3
zinc finger protein 608-like, transcript variant X4
zinc finger protein 608-like, transcript variant X10
zinc finger protein 608-like, transcript variant X1
zinc finger protein 608-like, transcript variant X3
zinc finger protein 608-like, transcript variant X5
zinc finger protein 608-like, transcript variant X11
zinc finger protein 608-like, transcript variant X6
zinc finger protein 608-like, transcript variant X9
zinc finger protein 608-like, transcript variant X7
zinc finger protein 608-like, transcript variant X8
zinc finger protein 608-like, transcript variant X2
protein immune deficiency, transcript variant X1
protein immune deficiency, transcript variant X2
uncharacterized LOC114878734, transcript variant X2
uncharacterized LOC114878734, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
adenosine 3'-phospho 5'-phosphosulfate transporter 1, transcript variant X3
adenosine 3'-phospho 5'-phosphosulfate transporter 1, transcript variant X1
adenosine 3'-phospho 5'-phosphosulfate transporter 1, transcript variant X2
adenosine 3'-phospho 5'-phosphosulfate transporter 1
transmembrane protein 216-like, transcript variant X1
transmembrane protein 216-like, transcript variant X2
transmembrane protein 216-like, transcript variant X3
uncharacterized aarF domain-containing protein kinase 2-like, transcript variant X3
uncharacterized aarF domain-containing protein kinase 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized aarF domain-containing protein kinase 2-like, transcript variant X2
uncharacterized aarF domain-containing protein kinase 2-like isoform X1
uncharacterized aarF domain-containing protein kinase 2-like isoform X2
uncharacterized aarF domain-containing protein kinase 2-like isoform X3
uncharacterized aarF domain-containing protein kinase 2-like, transcript variant X4
uncharacterized aarF domain-containing protein kinase 2-like isoform X4
ecdysone 20-monooxygenase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 46 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ecdysone 20-monooxygenase, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 46 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
ecdysone 20-monooxygenase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 46 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
ecdysone 20-monooxygenase, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 46 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
ubiquinone biosynthesis monooxygenase COQ6, mitochondrial
transient receptor potential channel pyrexia, transcript variant X3
transient receptor potential channel pyrexia, transcript variant X2
transient receptor potential channel pyrexia, transcript variant X7
transient receptor potential channel pyrexia, transcript variant X5
transient receptor potential channel pyrexia, transcript variant X4
transient receptor potential channel pyrexia, transcript variant X8
transient receptor potential channel pyrexia, transcript variant X1
transient receptor potential channel pyrexia, transcript variant X6
transient receptor potential channel pyrexia isoform X3
transient receptor potential channel pyrexia isoform X2
transient receptor potential channel pyrexia isoform X5
transient receptor potential channel pyrexia isoform X1
transient receptor potential channel pyrexia isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
conserved oligomeric Golgi complex subunit 4, transcript variant X1
conserved oligomeric Golgi complex subunit 4, transcript variant X2
conserved oligomeric Golgi complex subunit 4 isoform X1
conserved oligomeric Golgi complex subunit 4 isoform X2
broad-complex core protein isoforms 1/2/3/4/5-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
broad-complex core protein isoforms 1/2/3/4/5-like, transcript variant X4
broad-complex core protein isoforms 1/2/3/4/5-like, transcript variant X1
broad-complex core protein isoforms 1/2/3/4/5-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
broad-complex core protein isoforms 1/2/3/4/5-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
broad-complex core protein isoforms 1/2/3/4/5-like isoform X5
broad-complex core protein isoforms 1/2/3/4/5-like isoform X4
broad-complex core protein isoforms 1/2/3/4/5-like isoform X1
broad-complex core protein isoforms 1/2/3/4/5-like isoform X2
broad-complex core protein isoforms 1/2/3/4/5-like isoform X3
transcription and mRNA export factor ENY2
mitochondrial import inner membrane translocase subunit Tim21
T-box transcription factor TBX20-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
T-box transcription factor TBX20-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
T-box transcription factor TBX20-like isoform X1
T-box transcription factor TBX20-like isoform X2
T-box protein H15-like, transcript variant X4
T-box protein H15-like, transcript variant X3
T-box protein H15-like, transcript variant X2
T-box protein H15-like, transcript variant X1
WD repeat and FYVE domain-containing protein 2
DNA excision repair protein ERCC-5, transcript variant X3
DNA excision repair protein ERCC-5, transcript variant X1
DNA excision repair protein ERCC-5, transcript variant X2
DNA excision repair protein ERCC-5 isoform X1
DNA excision repair protein ERCC-5, transcript variant X4
DNA excision repair protein ERCC-5 isoform X2
zinc finger protein 70-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
zinc finger protein 70-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
zinc finger protein 70-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
zinc finger protein 70-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
zinc finger protein 70-like, transcript variant X1
uncharacterized LOC114882845, transcript variant X3
uncharacterized LOC114882845, transcript variant X2
uncharacterized LOC114882845, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
ADP/ATP translocase 4-like, transcript variant X4
ADP/ATP translocase 4-like, transcript variant X2
ADP/ATP translocase 4-like, transcript variant X3
ADP/ATP translocase 4-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
transmembrane protein 8B, transcript variant X1
transmembrane protein 8B, transcript variant X4
transmembrane protein 8B, transcript variant X2
transmembrane protein 8B, transcript variant X3
transmembrane protein 8B, transcript variant X5
probable ATP-dependent RNA helicase spindle-E, transcript variant X2
probable ATP-dependent RNA helicase spindle-E, transcript variant X5
probable ATP-dependent RNA helicase spindle-E, transcript variant X1
probable ATP-dependent RNA helicase spindle-E, transcript variant X4
probable ATP-dependent RNA helicase spindle-E, transcript variant X3
probable ATP-dependent RNA helicase spindle-E
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit epsilon isoform, transcript variant X2
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit epsilon isoform, transcript variant X1
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit epsilon isoform isoform X1
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit epsilon isoform, transcript variant X3
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit epsilon isoform isoform X2
protein salvador homolog 1-like, transcript variant X1
protein salvador homolog 1-like, transcript variant X5
protein salvador homolog 1-like, transcript variant X3
protein salvador homolog 1-like, transcript variant X2
protein salvador homolog 1-like, transcript variant X4
scaffold protein salvador-like isoform X1
protein salvador homolog 1-like isoform X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00286
choline-phosphate cytidylyltransferase A-like, transcript variant X8
choline-phosphate cytidylyltransferase A-like, transcript variant X9
choline-phosphate cytidylyltransferase A-like, transcript variant X2
choline-phosphate cytidylyltransferase A-like, transcript variant X3
choline-phosphate cytidylyltransferase A-like, transcript variant X1
choline-phosphate cytidylyltransferase A-like, transcript variant X6
choline-phosphate cytidylyltransferase A-like, transcript variant X4
choline-phosphate cytidylyltransferase A-like, transcript variant X5
choline-phosphate cytidylyltransferase A-like, transcript variant X7
choline-phosphate cytidylyltransferase A-like isoform X1
choline-phosphate cytidylyltransferase A-like isoform X2
hemicentin-2-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 69 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
hemicentin-2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 41 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 27% coverage of the annotated genomic feature by RNAseq alignments
hemicentin-2-like, transcript variant X1
hemicentin-2-like, transcript variant X5
hemicentin-2-like, transcript variant X2
uncharacterized LOC114882855, transcript variant X7
uncharacterized LOC114882855, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
uncharacterized LOC114882855, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC114882855, transcript variant X1
uncharacterized LOC114882855, transcript variant X8
uncharacterized LOC114882855, transcript variant X2
uncharacterized protein LOC114882855 isoform X1
uncharacterized protein LOC114882855 isoform X2
uncharacterized LOC114882855, transcript variant X4
uncharacterized LOC114882855, transcript variant X5
hemicentin-1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
hemicentin-1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
hemicentin-1-like, transcript variant X5
hemicentin-1-like, transcript variant X3
hemicentin-1-like, transcript variant X6
hemicentin-1-like, transcript variant X1
elongation of very long chain fatty acids protein 1-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 83% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: elongation of very long chain fatty acids protein 1-like
cysteine sulfinic acid decarboxylase-like, transcript variant X1
cysteine sulfinic acid decarboxylase-like, transcript variant X2
cysteine sulfinic acid decarboxylase-like
protein UXT homolog, transcript variant X2
protein UXT homolog, transcript variant X1
homeobox protein prospero, transcript variant X4
homeobox protein prospero, transcript variant X2
homeobox protein prospero, transcript variant X3
homeobox protein prospero, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
C-1-tetrahydrofolate synthase, cytoplasmic, transcript variant X1
C-1-tetrahydrofolate synthase, cytoplasmic isoform X1
C-1-tetrahydrofolate synthase, cytoplasmic, transcript variant X2
C-1-tetrahydrofolate synthase, cytoplasmic isoform X2
probable methyltransferase-like protein 15 homolog
transfer RNA cysteine (anticodon GCA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
cyclin-dependent kinase-like 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
cyclin-dependent kinase-like 4 isoform X1
cyclin-dependent kinase-like 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
cyclin-dependent kinase-like 4 isoform X3
cyclin-dependent kinase-like 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
cyclin-dependent kinase-like 4 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
TRAF3-interacting protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
TRAF3-interacting protein 1, transcript variant X2
protein Wnt-7b-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 130 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
protein Wnt-7b-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 130 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
regulator of microtubule dynamics protein 1-like, transcript variant X1
regulator of microtubule dynamics protein 1-like, transcript variant X2
regulator of microtubule dynamics protein 1-like
peptidyl-prolyl cis-trans isomerase FKBP62-like
uncharacterized LOC114882871, transcript variant X1
uncharacterized protein LOC114882871 isoform X1
uncharacterized LOC114882871, transcript variant X2
uncharacterized LOC114882871, transcript variant X3
uncharacterized protein LOC114882871 isoform X2
uncharacterized protein LOC114882871 isoform X3
angiogenic factor with G patch and FHA domains 1, transcript variant X2
angiogenic factor with G patch and FHA domains 1, transcript variant X1
angiogenic factor with G patch and FHA domains 1
dnaJ homolog subfamily C member 13, transcript variant X1
dnaJ homolog subfamily C member 13, transcript variant X2
dnaJ homolog subfamily C member 13 isoform X1
dnaJ homolog subfamily C member 13 isoform X2
WD repeat-containing protein 20, transcript variant X4
WD repeat-containing protein 20, transcript variant X3
WD repeat-containing protein 20, transcript variant X1
WD repeat-containing protein 20, transcript variant X2
WD repeat-containing protein 20 isoform X2
WD repeat-containing protein 20 isoform X1
ADP-ribosylation factor-binding protein GGA1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
ADP-ribosylation factor-binding protein GGA1, transcript variant X1
ADP-ribosylation factor-binding protein GGA1 isoform X2
ADP-ribosylation factor-binding protein GGA1 isoform X1
target of rapamycin complex subunit lst8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
SAP30-binding protein, transcript variant X1
SAP30-binding protein, transcript variant X3
SAP30-binding protein, transcript variant X2
SAP30-binding protein, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
proteasome activator complex subunit 4A-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 26 bases in 21 codons; deleted 17 bases in 15 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 48% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 26 bases in 21 codons; deleted 17 bases in 15 codons; substituted 21 bases at 21 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: proteasome activator complex subunit 4A-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 7 bases in 5 codons; deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 7 bases in 5 codons; deleted 1 base in 1 codon; substituted 3 bases at 3 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: alpha-mannosidase 2
N-alpha-acetyltransferase 40, transcript variant X4
N-alpha-acetyltransferase 40, transcript variant X3
N-alpha-acetyltransferase 40, transcript variant X1
N-alpha-acetyltransferase 40, transcript variant X2
3'-5' ssDNA/RNA exonuclease TatD, transcript variant X2
3'-5' ssDNA/RNA exonuclease TatD, transcript variant X1
3'-5' ssDNA/RNA exonuclease TatD, transcript variant X3
3'-5' ssDNA/RNA exonuclease TatD, transcript variant X4
uncharacterized LOC114880560, transcript variant X1
uncharacterized protein LOC114880560 isoform X1
uncharacterized LOC114880560, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
uncharacterized protein LOC114880560 isoform X2
uncharacterized LOC114880574, transcript variant X1
uncharacterized LOC114880574, transcript variant X2
uncharacterized protein LOC114880574 isoform X1
uncharacterized LOC114880574, transcript variant X3
uncharacterized LOC114880574, transcript variant X4
uncharacterized protein LOC114880574 isoform X2
signal recognition particle 14 kDa protein
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 6 bases in 6 codons; deleted 12 bases in 10 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 6 bases in 6 codons; deleted 12 bases in 10 codons; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: zinc finger protein 2 homolog
lysophospholipase-like protein 1, transcript variant X2
lysophospholipase-like protein 1, transcript variant X1
lysophospholipase-like protein 1 isoform X1
lysophospholipase-like protein 1 isoform X2
complement component 1 Q subcomponent-binding protein, mitochondrial, transcript variant X2
complement component 1 Q subcomponent-binding protein, mitochondrial, transcript variant X1
complement component 1 Q subcomponent-binding protein, mitochondrial isoform X2
complement component 1 Q subcomponent-binding protein, mitochondrial isoform X1
diphthine methyl ester synthase, transcript variant X2
diphthine methyl ester synthase, transcript variant X1
diphthine methyl ester synthase, transcript variant X3
E3 ubiquitin-protein ligase RNF139-like, transcript variant X2
E3 ubiquitin-protein ligase RNF139-like, transcript variant X3
E3 ubiquitin-protein ligase RNF139-like, transcript variant X1
E3 ubiquitin-protein ligase RNF139-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
39S ribosomal protein L40, mitochondrial
cytoplasmic tRNA 2-thiolation protein 2-A
homeobox protein TGIF2LX-like, transcript variant X3
homeobox protein TGIF2LX-like isoform X3
homeobox protein TGIF2LX-like, transcript variant X1
homeobox protein TGIF2LX-like, transcript variant X4
homeobox protein TGIF2LX-like isoform X4
homeobox protein TGIF2LX-like, transcript variant X2
homeobox protein TGIF2LX-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
39S ribosomal protein L17, mitochondrial
2-oxoisovalerate dehydrogenase subunit alpha, mitochondrial, transcript variant X2
2-oxoisovalerate dehydrogenase subunit alpha, mitochondrial, transcript variant X1
2-oxoisovalerate dehydrogenase subunit alpha, mitochondrial
steroid hormone receptor ERR2, transcript variant X6
steroid hormone receptor ERR2 isoform X6
steroid hormone receptor ERR2, transcript variant X5
steroid hormone receptor ERR2, transcript variant X7
steroid hormone receptor ERR2 isoform X5
steroid hormone receptor ERR2 isoform X7
uncharacterized LOC114877377, transcript variant X2
uncharacterized LOC114877377, transcript variant X1
steroid hormone receptor ERR2, transcript variant X1
steroid hormone receptor ERR2, transcript variant X3
steroid hormone receptor ERR2, transcript variant X8
steroid hormone receptor ERR2, transcript variant X2
steroid hormone receptor ERR2, transcript variant X4
steroid hormone receptor ERR2 isoform X1
steroid hormone receptor ERR2 isoform X3
steroid hormone receptor ERR1 isoform X8
steroid hormone receptor ERR2 isoform X2
steroid hormone receptor ERR2 isoform X4
uncharacterized LOC114877378, transcript variant X1
uncharacterized LOC114877378, transcript variant X2
uncharacterized protein LOC114877378 isoform X1
uncharacterized protein LOC114877378 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments
glucose dehydrogenase [FAD, quinone]-like, transcript variant X2
glucose dehydrogenase [FAD, quinone]-like, transcript variant X4
glucose dehydrogenase [FAD, quinone]-like, transcript variant X3
glucose dehydrogenase [FAD, quinone]-like, transcript variant X1
glucose dehydrogenase [FAD, quinone]-like, transcript variant X5
glucose dehydrogenase [FAD, quinone]-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
aprataxin and PNK-like factor, transcript variant X2
aprataxin and PNK-like factor, transcript variant X1
aprataxin and PNK-like factor isoform X2
aprataxin and PNK-like factor isoform X1
feline leukemia virus subgroup C receptor-related protein 2-like, transcript variant X2
feline leukemia virus subgroup C receptor-related protein 2-like, transcript variant X3
feline leukemia virus subgroup C receptor-related protein 2-like, transcript variant X1
feline leukemia virus subgroup C receptor-related protein 2-like isoform X2
feline leukemia virus subgroup C receptor-related protein 2-like isoform X1
uncharacterized LOC114878487, transcript variant X2
uncharacterized LOC114878487, transcript variant X4
uncharacterized LOC114878487, transcript variant X1
uncharacterized LOC114878487, transcript variant X3
uncharacterized LOC114878487, transcript variant X5
uncharacterized LOC114878487, transcript variant X6
uncharacterized protein LOC114878487 isoform X1
uncharacterized protein LOC114878487 isoform X4
uncharacterized protein LOC114878487 isoform X2
uncharacterized protein LOC114878487 isoform X5
uncharacterized protein LOC114878487 isoform X3
uncharacterized protein LOC114878487 isoform X6
uncharacterized LOC114878487, transcript variant X10
uncharacterized LOC114878487, transcript variant X7
uncharacterized LOC114878487, transcript variant X8
uncharacterized LOC114878487, transcript variant X9
uncharacterized protein LOC114878487 isoform X7
golgin subfamily A member 6-like protein 22
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 63% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC114878475, transcript variant X2
uncharacterized LOC114878475, transcript variant X1
uncharacterized protein LOC114878475 isoform X2
uncharacterized protein LOC114878475 isoform X1
NEDD8-conjugating enzyme UBE2F-like, transcript variant X4
NEDD8-conjugating enzyme UBE2F-like, transcript variant X2
NEDD8-conjugating enzyme UBE2F-like, transcript variant X3
NEDD8-conjugating enzyme UBE2F-like, transcript variant X1
vacuolar protein-sorting-associated protein 25
cyclin-dependent kinases regulatory subunit-like, transcript variant X2
cyclin-dependent kinases regulatory subunit-like isoform X2
cyclin-dependent kinases regulatory subunit-like, transcript variant X1
cyclin-dependent kinases regulatory subunit-like isoform X1
protein PRRC1-A-like, transcript variant X2
protein PRRC1-A-like, transcript variant X4
protein PRRC1-A-like, transcript variant X3
protein PRRC1-A-like, transcript variant X1
mitochondrial uncoupling protein Bmcp, transcript variant X1
mitochondrial uncoupling protein Bmcp, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
mitochondrial uncoupling protein Bmcp, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
mitochondrial uncoupling protein Bmcp, transcript variant X8
mitochondrial uncoupling protein Bmcp isoform X1
mitochondrial uncoupling protein Bmcp, transcript variant X5
mitochondrial uncoupling protein Bmcp, transcript variant X3
mitochondrial uncoupling protein Bmcp, transcript variant X4
mitochondrial uncoupling protein Bmcp, transcript variant X2
mitochondrial uncoupling protein Bmcp isoform X2
mitochondrial uncoupling protein Bmcp isoform X3
ADP-ribosylation factor-like protein 6-interacting protein 6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
ubiquitin carboxyl-terminal hydrolase 5, transcript variant X2
ubiquitin carboxyl-terminal hydrolase 5, transcript variant X1
translation initiation factor IF-2, mitochondrial
LOW QUALITY PROTEIN: UPF0676 protein C1494.01
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 41% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: uncharacterized protein LOC114878496
uncharacterized LOC114878495, transcript variant X2
uncharacterized LOC114878495, transcript variant X1
uncharacterized LOC114878486, transcript variant X2
uncharacterized LOC114878486, transcript variant X1
axoneme-associated protein mst101(2)-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 96% coverage of the annotated genomic feature by RNAseq alignments
homeobox protein six1a, transcript variant X4
homeobox protein six1a, transcript variant X1
homeobox protein six1a, transcript variant X3
homeobox protein six1a, transcript variant X2
kinesin-like protein KIF21A, transcript variant X1
kinesin-like protein KIF21A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
bifunctional arginine demethylase and lysyl-hydroxylase PSR, transcript variant X2
bifunctional arginine demethylase and lysyl-hydroxylase PSR, transcript variant X1
bifunctional arginine demethylase and lysyl-hydroxylase PSR, transcript variant X5
bifunctional arginine demethylase and lysyl-hydroxylase PSR, transcript variant X4
bifunctional arginine demethylase and lysyl-hydroxylase PSR, transcript variant X3
bifunctional arginine demethylase and lysyl-hydroxylase PSR isoform X2
bifunctional arginine demethylase and lysyl-hydroxylase PSR isoform X1
bifunctional arginine demethylase and lysyl-hydroxylase PSR isoform X3
histone-lysine N-methyltransferase, H3 lysine-79 specific, transcript variant X1
histone-lysine N-methyltransferase, H3 lysine-79 specific, transcript variant X2
histone-lysine N-methyltransferase, H3 lysine-79 specific, transcript variant X3
histone-lysine N-methyltransferase, H3 lysine-79 specific isoform X1
histone-lysine N-methyltransferase, H3 lysine-79 specific isoform X2
A disintegrin and metalloproteinase with thrombospondin motifs adt-2-like
dnaJ protein homolog 1-like, transcript variant X1
dnaJ protein homolog 1-like, transcript variant X2
dynein axonemal heavy chain 12-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
dynein axonemal heavy chain 12-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
dynein axonemal heavy chain 12-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
dynein axonemal heavy chain 12-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
dynein axonemal heavy chain 12-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
dynein axonemal heavy chain 12-like, transcript variant X6
dynein axonemal heavy chain 12-like isoform X1
dynein axonemal heavy chain 12-like isoform X2
dynein axonemal heavy chain 12-like, transcript variant X7
dynein axonemal heavy chain 12-like isoform X3
uncharacterized LOC114878473, transcript variant X2
uncharacterized LOC114878473, transcript variant X1
probable cleavage and polyadenylation specificity factor subunit 2
uncharacterized LOC114875335, transcript variant X1
uncharacterized LOC114875335, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins
serine/arginine repetitive matrix protein 2-like
two pore potassium channel protein sup-9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 33% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 65 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 65 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 70 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 59 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 65 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 3% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC114875327, transcript variant X1
uncharacterized LOC114875327, transcript variant X2
homeobox protein homothorax, transcript variant X5
homeobox protein homothorax, transcript variant X2
homeobox protein homothorax, transcript variant X4
homeobox protein homothorax, transcript variant X3
homeobox protein homothorax, transcript variant X1
beclin-1-like protein, transcript variant X1
beclin-1-like protein, transcript variant X2
uridine diphosphate glucose pyrophosphatase NUDT14-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 19% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 16% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 23% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
spliceosome-associated protein CWC27 homolog
uncharacterized LOC114877551, transcript variant X1
uncharacterized LOC114877551, transcript variant X3
uncharacterized LOC114877551, transcript variant X2
uncharacterized protein LOC114877551 isoform X2
uncharacterized protein LOC114877551 isoform X1
uncharacterized protein LOC114877551 isoform X3
serine/threonine-protein kinase PRP4 homolog
uncharacterized LOC114877550, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
uncharacterized LOC114877550, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
uncharacterized LOC114877550, transcript variant X1
uncharacterized LOC114877550, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized protein LOC114877550 isoform X2
uncharacterized protein LOC114877550 isoform X1
uncharacterized protein LOC114877550 isoform X3
putative ferric-chelate reductase 1 homolog, transcript variant X2
putative ferric-chelate reductase 1 homolog, transcript variant X1
putative ferric-chelate reductase 1 homolog isoform X1
putative ferric-chelate reductase 1 homolog, transcript variant X3
putative ferric-chelate reductase 1 homolog isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
acetylcholine receptor subunit beta-like 2, transcript variant X1
acetylcholine receptor subunit beta-like 2, transcript variant X2
acetylcholine receptor subunit beta-like 2, transcript variant X3
acetylcholine receptor subunit beta-like 2, transcript variant X4
acetylcholine receptor subunit beta-like 2 isoform X1
acetylcholine receptor subunit beta-like 2 isoform X2
acetylcholine receptor subunit beta-like 2 isoform X3
acetylcholine receptor subunit beta-like 2 isoform X4
E3 SUMO-protein ligase PIAS2, transcript variant X2
E3 SUMO-protein ligase PIAS2, transcript variant X4
E3 SUMO-protein ligase PIAS2, transcript variant X1
E3 SUMO-protein ligase PIAS2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
tripartite motif-containing protein 2-like, transcript variant X2
tripartite motif-containing protein 2-like isoform X2
tripartite motif-containing protein 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
tripartite motif-containing protein 2-like isoform X1
tripartite motif-containing protein 2-like, transcript variant X3
tripartite motif-containing protein 2-like isoform X3
protein FAM117B-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
protein FAM117B-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
protein FAM117B-like, transcript variant X3
SH3KBP1-binding protein 1, transcript variant X3
SH3KBP1-binding protein 1, transcript variant X1
SH3KBP1-binding protein 1, transcript variant X2
SH3KBP1-binding protein 1, transcript variant X4
CAAX prenyl protease 2, transcript variant X1
CAAX prenyl protease 2, transcript variant X3
CAAX prenyl protease 2, transcript variant X2
F-box only protein 11, transcript variant X8
F-box only protein 11, transcript variant X1
F-box only protein 11, transcript variant X6
F-box only protein 11, transcript variant X7
F-box only protein 11, transcript variant X4
F-box only protein 11, transcript variant X3
F-box only protein 11, transcript variant X2
F-box only protein 11, transcript variant X5
F-box only protein 11, transcript variant X9
mediator of RNA polymerase II transcription subunit 6, transcript variant X3
mediator of RNA polymerase II transcription subunit 6, transcript variant X4
mediator of RNA polymerase II transcription subunit 6, transcript variant X2
mediator of RNA polymerase II transcription subunit 6, transcript variant X1
mediator of RNA polymerase II transcription subunit 6
solute carrier family 66 member 2, transcript variant X2
solute carrier family 66 member 2, transcript variant X1
dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 4
putative transferase CAF17 homolog, mitochondrial
tubulin--tyrosine ligase-like protein 12
uncharacterized LOC114877828, transcript variant X3
uncharacterized LOC114877828, transcript variant X1
uncharacterized LOC114877828, transcript variant X2
uncharacterized LOC114877828, transcript variant X4
uncharacterized protein LOC114877828 isoform X1
uncharacterized protein LOC114877828 isoform X2
kinesin-related protein 8-like, transcript variant X1
kinesin-related protein 8-like, transcript variant X3
kinesin-related protein 8-like, transcript variant X2
kinesin-related protein 8-like isoform X1
uncharacterized protein LOC114877837 isoform X2
uncharacterized protein LOC114877837 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
bromodomain-containing protein 7, transcript variant X4
bromodomain-containing protein 7, transcript variant X3
bromodomain-containing protein 7, transcript variant X8
bromodomain-containing protein 7, transcript variant X7
bromodomain-containing protein 7, transcript variant X6
bromodomain-containing protein 7, transcript variant X5
bromodomain-containing protein 7, transcript variant X2
bromodomain-containing protein 7, transcript variant X1
bromodomain-containing protein 7 isoform X4
bromodomain-containing protein 7 isoform X3
bromodomain-containing protein 7 isoform X2
bromodomain-containing protein 7 isoform X1
bromodomain-containing protein 7 isoform X5
solute carrier family 12 member 4, transcript variant X1
solute carrier family 12 member 4, transcript variant X2
solute carrier family 12 member 4, transcript variant X3
solute carrier family 12 member 4 isoform X1
solute carrier family 12 member 4 isoform X2
solute carrier family 12 member 4 isoform X3
solute carrier family 12 member 4, transcript variant X5
solute carrier family 12 member 6 isoform X5
solute carrier family 12 member 4, transcript variant X4
solute carrier family 12 member 4 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
PRKC apoptosis WT1 regulator protein-like, transcript variant X1
PRKC apoptosis WT1 regulator protein-like, transcript variant X4
PRKC apoptosis WT1 regulator protein-like, transcript variant X7
PRKC apoptosis WT1 regulator protein-like, transcript variant X3
PRKC apoptosis WT1 regulator protein-like, transcript variant X2
PRKC apoptosis WT1 regulator protein-like, transcript variant X8
PRKC apoptosis WT1 regulator protein-like, transcript variant X6
PRKC apoptosis WT1 regulator protein-like, transcript variant X5
PRKC apoptosis WT1 regulator protein-like, transcript variant X9
PRKC apoptosis WT1 regulator protein-like isoform X1
PRKC apoptosis WT1 regulator protein-like isoform X5
PRKC apoptosis WT1 regulator protein-like isoform X3
PRKC apoptosis WT1 regulator protein-like isoform X2
PRKC apoptosis WT1 regulator protein-like isoform X4
dual specificity protein phosphatase 10-like, transcript variant X1
dual specificity protein phosphatase 10-like, transcript variant X2
dual specificity protein phosphatase 10-like isoform X1
dual specificity protein phosphatase 10-like isoform X2
tyrosine-protein phosphatase non-receptor type 14, transcript variant X1
tyrosine-protein phosphatase non-receptor type 14, transcript variant X2
tyrosine-protein phosphatase non-receptor type 14, transcript variant X3
tyrosine-protein phosphatase non-receptor type 14, transcript variant X4
tyrosine-protein phosphatase non-receptor type 14 isoform X1
tyrosine-protein phosphatase non-receptor type 14 isoform X2
uncharacterized LOC114877289, transcript variant X2
uncharacterized LOC114877289, transcript variant X1
lysM and putative peptidoglycan-binding domain-containing protein 3, transcript variant X4
lysM and putative peptidoglycan-binding domain-containing protein 3, transcript variant X1
lysM and putative peptidoglycan-binding domain-containing protein 3, transcript variant X2
lysM and putative peptidoglycan-binding domain-containing protein 3, transcript variant X3
lysM and putative peptidoglycan-binding domain-containing protein 3
cytochrome c oxidase assembly factor 5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
cytochrome c oxidase assembly factor 5, transcript variant X1
uncharacterized LOC114877282, transcript variant X5
uncharacterized LOC114877282, transcript variant X3
uncharacterized LOC114877282, transcript variant X2
uncharacterized LOC114877282, transcript variant X1
uncharacterized LOC114877282, transcript variant X4
uncharacterized protein LOC114877282 isoform X3
uncharacterized protein LOC114877282 isoform X2
uncharacterized protein LOC114877282 isoform X1
monocarboxylate transporter 10, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
monocarboxylate transporter 10, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
monocarboxylate transporter 10, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
monocarboxylate transporter 10, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
monocarboxylate transporter 10, transcript variant X5
monocarboxylate transporter 10 isoform X1
monocarboxylate transporter 10 isoform X2
monocarboxylate transporter 3, transcript variant X2
monocarboxylate transporter 3, transcript variant X1
monocarboxylate transporter 3, transcript variant X5
monocarboxylate transporter 3, transcript variant X4
monocarboxylate transporter 3, transcript variant X3
monocarboxylate transporter 3 isoform X2
monocarboxylate transporter 3 isoform X1
monocarboxylate transporter 3 isoform X5
monocarboxylate transporter 3 isoform X4
monocarboxylate transporter 3 isoform X3
delta(14)-sterol reductase TM7SF2, transcript variant X2
delta(14)-sterol reductase TM7SF2, transcript variant X1
delta(14)-sterol reductase TM7SF2, transcript variant X5
delta(14)-sterol reductase TM7SF2 isoform X1
heat shock factor 2-binding protein-like, transcript variant X2
heat shock factor 2-binding protein-like, transcript variant X1
heat shock factor 2-binding protein-like
delta(14)-sterol reductase TM7SF2, transcript variant X3
delta(14)-sterol reductase TM7SF2 isoform X2
delta(14)-sterol reductase TM7SF2, transcript variant X4
delta(14)-sterol reductase TM7SF2 isoform X3
proteasome assembly chaperone 1, transcript variant X1
proteasome assembly chaperone 1, transcript variant X2
testis-specific serine/threonine-protein kinase 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
zinc transporter 7, transcript variant X1
zinc transporter 7, transcript variant X2
uncharacterized LOC114877278, transcript variant X3
uncharacterized LOC114877278, transcript variant X5
uncharacterized LOC114877278, transcript variant X2
uncharacterized LOC114877278, transcript variant X4
uncharacterized LOC114877278, transcript variant X6
uncharacterized LOC114877278, transcript variant X1
uncharacterized protein LOC114877278 isoform X2
uncharacterized protein LOC114877278 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC114877300, transcript variant X2
uncharacterized LOC114877300, transcript variant X1
uncharacterized protein LOC114877300 isoform X2
uncharacterized protein LOC114877300 isoform X1
uncharacterized LOC114877300, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
uncharacterized protein LOC114877300 isoform X3
protein FAM50 homolog, transcript variant X2
protein FAM50 homolog, transcript variant X1
protein FAM50 homolog, transcript variant X3
protein FAM50 homolog, transcript variant X4
nucleoporin SEH1-A, transcript variant X1
nucleoporin SEH1-A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 58% coverage of the annotated genomic feature by RNAseq alignments
regulator of G-protein signaling 17, transcript variant X6
regulator of G-protein signaling 17 isoform X6
regulator of G-protein signaling 17, transcript variant X3
zinc finger protein 335, transcript variant X6
zinc finger protein 335, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
zinc finger protein 335, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
zinc finger protein 335, transcript variant X3
zinc finger protein 335, transcript variant X2
zinc finger protein 335, transcript variant X4
zinc finger protein 335, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized protein LOC114877688 isoform X2
uncharacterized protein LOC114877688 isoform X1
regulator of G-protein signaling 17, transcript variant X1
regulator of G-protein signaling 17, transcript variant X4
regulator of G-protein signaling 17, transcript variant X2
regulator of G-protein signaling 17, transcript variant X5
regulator of G-protein signaling 17 isoform X1
regulator of G-protein signaling 17 isoform X4
regulator of G-protein signaling 17 isoform X2
regulator of G-protein signaling 17 isoform X5
regulator of G-protein signaling 17 isoform X3
nuclear receptor subfamily 4 group A member 3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 98% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 63% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: uncharacterized protein LOC114877710
protein grainyhead, transcript variant X1
protein grainyhead, transcript variant X2
protein grainyhead, transcript variant X3
proclotting enzyme-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 67 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
proclotting enzyme-like, transcript variant X1
serine/threonine-protein kinase greatwall
serine/threonine-protein kinase VRK1-like
nuclear export mediator factor NEMF homolog
uncharacterized LOC114877694, transcript variant X1
uncharacterized LOC114877694, transcript variant X3
uncharacterized LOC114877694, transcript variant X2
uncharacterized protein LOC114877694 isoform X1
uncharacterized protein LOC114877694 isoform X3
uncharacterized protein LOC114877694 isoform X2
uncharacterized LOC114877694, transcript variant X4
uncharacterized protein LOC114877694 isoform X4
putative epidermal cell surface receptor, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
putative epidermal cell surface receptor, transcript variant X2
putative epidermal cell surface receptor, transcript variant X3
putative epidermal cell surface receptor, transcript variant X4
putative epidermal cell surface receptor isoform X1
putative epidermal cell surface receptor isoform X2
putative epidermal cell surface receptor isoform X3
putative epidermal cell surface receptor isoform X4
probable phospholipid hydroperoxide glutathione peroxidase
probable cardiolipin synthase (CMP-forming), transcript variant X1
probable cardiolipin synthase (CMP-forming), transcript variant X4
probable cardiolipin synthase (CMP-forming), transcript variant X3
probable cardiolipin synthase (CMP-forming), transcript variant X2
probable cardiolipin synthase (CMP-forming)
complex I intermediate-associated protein 30, mitochondrial
polyribonucleotide nucleotidyltransferase 1, mitochondrial, transcript variant X1
polyribonucleotide nucleotidyltransferase 1, mitochondrial isoform X1
polyribonucleotide nucleotidyltransferase 1, mitochondrial, transcript variant X2
polyribonucleotide nucleotidyltransferase 1, mitochondrial isoform X2
TLR4 interactor with leucine rich repeats-like
leucine-rich repeat-containing protein 15-like
leucine-rich repeat-containing G-protein coupled receptor 5-like
leucine-rich repeat and death domain-containing protein 1-like
protein phosphatase 1 regulatory subunit pprA-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
neutral and basic amino acid transport protein rBAT-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
neutral and basic amino acid transport protein rBAT-like, transcript variant X2
neutral and basic amino acid transport protein rBAT-like isoform X1
neutral and basic amino acid transport protein rBAT-like isoform X2
mitochondrial glutamate carrier 1-like, transcript variant X1
mitochondrial glutamate carrier 1-like, transcript variant X3
mitochondrial glutamate carrier 1-like, transcript variant X2
tight junction protein ZO-1, transcript variant X1
tight junction protein ZO-1, transcript variant X2
tight junction protein ZO-1, transcript variant X4
tight junction protein ZO-1, transcript variant X3
tight junction protein ZO-1, transcript variant X5
uncharacterized LOC114875691, transcript variant X2
uncharacterized LOC114875691, transcript variant X3
uncharacterized LOC114875691, transcript variant X1
growth arrest-specific protein 1-like, transcript variant X5
growth arrest-specific protein 1-like, transcript variant X3
growth arrest-specific protein 1-like, transcript variant X1
growth arrest-specific protein 1-like, transcript variant X4
growth arrest-specific protein 1-like, transcript variant X2
growth arrest-specific protein 1-like, transcript variant X7
growth arrest-specific protein 1-like, transcript variant X8
growth arrest-specific protein 1-like, transcript variant X6
growth arrest-specific protein 1-like isoform X2
growth arrest-specific protein 1-like isoform X1
probable 26S proteasome non-ATPase regulatory subunit 3
golgin subfamily A member 2, transcript variant X2
golgin subfamily A member 2, transcript variant X1
eukaryotic translation initiation factor 5A, transcript variant X3
eukaryotic translation initiation factor 5A, transcript variant X1
eukaryotic translation initiation factor 5A, transcript variant X4
eukaryotic translation initiation factor 5A, transcript variant X2
eukaryotic translation initiation factor 5A isoform X1
eukaryotic translation initiation factor 5A isoform X2
F-actin-capping protein subunit beta, transcript variant X1
F-actin-capping protein subunit beta, transcript variant X2
F-actin-capping protein subunit beta isoform X1
F-actin-capping protein subunit beta isoform X2
1-acyl-sn-glycerol-3-phosphate acyltransferase gamma-like, transcript variant X1
1-acyl-sn-glycerol-3-phosphate acyltransferase gamma-like, transcript variant X2
1-acyl-sn-glycerol-3-phosphate acyltransferase gamma-like
uncharacterized LOC114875711, transcript variant X1
uncharacterized LOC114875711, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized protein LOC114875711 isoform X1
uncharacterized protein LOC114875711 isoform X2
gustatory receptor for sugar taste 64f-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 56 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 84% coverage of the annotated genomic feature by RNAseq alignments
28S ribosomal protein S14, mitochondrial
elongation factor 1-alpha, transcript variant X1
elongation factor 1-alpha, transcript variant X2
cyclic nucleotide-gated cation channel alpha-3
RNA-binding protein Pasilla, transcript variant X3
RNA-binding protein Pasilla, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
RNA-binding protein Pasilla, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
RNA-binding protein Pasilla, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
RNA-binding protein Pasilla, transcript variant X1
RNA-binding protein Pasilla, transcript variant X4
molybdopterin synthase catalytic subunit
tubulin polyglutamylase TTLL5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
tubulin polyglutamylase TTLL5, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
tubulin polyglutamylase TTLL5, transcript variant X4
tubulin polyglutamylase TTLL5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 12% coverage of the annotated genomic feature by RNAseq alignments
tubulin polyglutamylase TTLL5 isoform X2
tubulin polyglutamylase TTLL5 isoform X1
tubulin polyglutamylase TTLL5 isoform X3
tubulin polyglutamylase TTLL5, transcript variant X5
uncharacterized LOC114875672, transcript variant X1
uncharacterized LOC114875672, transcript variant X2
uncharacterized LOC114875672, transcript variant X6
uncharacterized LOC114875672, transcript variant X5
uncharacterized LOC114875672, transcript variant X4
uncharacterized LOC114875672, transcript variant X3
uncharacterized protein LOC114875672 isoform X1
uncharacterized protein LOC114875672 isoform X2
tubulin polyglutamylase TTLL5 isoform X4
LOW QUALITY PROTEIN: uncharacterized protein LOC114875702
AT-rich interactive domain-containing protein 4B, transcript variant X1
AT-rich interactive domain-containing protein 4B, transcript variant X2
AT-rich interactive domain-containing protein 4B isoform X2
AT-rich interactive domain-containing protein 4B isoform X1
protein arginine N-methyltransferase 8, transcript variant X1
protein arginine N-methyltransferase 8, transcript variant X2
protein arginine N-methyltransferase 8, transcript variant X3
protein arginine N-methyltransferase 1 isoform X1
protein arginine N-methyltransferase 8, transcript variant X4
protein arginine N-methyltransferase 8, transcript variant X6
protein arginine N-methyltransferase 8, transcript variant X7
protein arginine N-methyltransferase 1 isoform X2
protein arginine N-methyltransferase 8, transcript variant X8
protein arginine N-methyltransferase 8, transcript variant X5
protein arginine N-methyltransferase 8 isoform X3
ras-related protein Rab-1A, transcript variant X2
ras-related protein Rab-1A, transcript variant X1
putative histone-lysine N-methyltransferase 1
LOW QUALITY PROTEIN: putative histone-lysine N-methyltransferase 1
uncharacterized LOC123988514, transcript variant X2
uncharacterized LOC123988514, transcript variant X1
adipocyte plasma membrane-associated protein-like
uncharacterized LOC114875726, transcript variant X2
uncharacterized LOC114875726, transcript variant X3
uncharacterized LOC114875726, transcript variant X4
uncharacterized LOC114875726, transcript variant X1
probable G-protein coupled receptor Mth-like 5, transcript variant X2
probable G-protein coupled receptor Mth-like 5, transcript variant X1
probable G-protein coupled receptor Mth-like 5
single-strand selective monofunctional uracil DNA glycosylase
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
probable tubulin polyglutamylase ttll-15, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
probable tubulin polyglutamylase ttll-15, transcript variant X1
probable tubulin polyglutamylase ttll-15
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 2 bases in 2 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: E3 ubiquitin-protein ligase TRIP12
zinc finger protein 184, transcript variant X2
zinc finger protein 184, transcript variant X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: uncharacterized protein LOC114875731
dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 20 bases in 17 codons; deleted 8 bases in 6 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 20 bases in 17 codons; deleted 8 bases in 6 codons; substituted 5 bases at 5 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon
LOW QUALITY PROTEIN: INO80 complex subunit D
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 2 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: uncharacterized protein LOC114875665
39S ribosomal protein L9, mitochondrial, transcript variant X1
39S ribosomal protein L9, mitochondrial, transcript variant X2
ubiquitin carboxyl-terminal hydrolase 34
transmembrane protein 245, transcript variant X1
transmembrane protein 245, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 84% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
cilia- and flagella-associated protein 57-like
mediator of RNA polymerase II transcription subunit 20
facilitated trehalose transporter Tret1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
facilitated trehalose transporter Tret1-2 homolog isoform X1
facilitated trehalose transporter Tret1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
facilitated trehalose transporter Tret1-like isoform X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 43% coverage of the annotated genomic feature by RNAseq alignments
histone acetyltransferase type B catalytic subunit, transcript variant X4
histone acetyltransferase type B catalytic subunit, transcript variant X1
histone acetyltransferase type B catalytic subunit, transcript variant X2
histone acetyltransferase type B catalytic subunit, transcript variant X3
histone acetyltransferase type B catalytic subunit
mitochondrial import inner membrane translocase subunit TIM14, transcript variant X2
mitochondrial import inner membrane translocase subunit TIM14, transcript variant X1
mitochondrial import inner membrane translocase subunit TIM14 isoform X2
mitochondrial import inner membrane translocase subunit TIM14 isoform X1
growth hormone-regulated TBC protein 1, transcript variant X2
growth hormone-regulated TBC protein 1, transcript variant X1
growth hormone-regulated TBC protein 1 isoform X2
growth hormone-regulated TBC protein 1 isoform X1
growth hormone-regulated TBC protein 1, transcript variant X3
growth hormone-regulated TBC protein 1-A isoform X3
eukaryotic translation initiation factor 2A
probable ubiquitin carboxyl-terminal hydrolase FAF-X, transcript variant X1
probable ubiquitin carboxyl-terminal hydrolase FAF-X, transcript variant X2
probable ubiquitin carboxyl-terminal hydrolase FAF-X, transcript variant X3
probable ubiquitin carboxyl-terminal hydrolase FAF-X
N-acetylgalactosaminyltransferase 6, transcript variant X1
N-acetylgalactosaminyltransferase 6, transcript variant X2
N-acetylgalactosaminyltransferase 6 isoform X2
N-acetylgalactosaminyltransferase 6 isoform X1
TLD domain-containing protein 2, transcript variant X11
TLD domain-containing protein 2, transcript variant X9
TLD domain-containing protein 2, transcript variant X8
TLD domain-containing protein 2, transcript variant X7
TLD domain-containing protein 2, transcript variant X2
TLD domain-containing protein 2, transcript variant X4
TLD domain-containing protein 2, transcript variant X6
TLD domain-containing protein 2, transcript variant X5
TLD domain-containing protein 2, transcript variant X3
TLD domain-containing protein 2, transcript variant X1
TLD domain-containing protein 2, transcript variant X10
TLD domain-containing protein 2, transcript variant X12
TLD domain-containing protein 2, transcript variant X15
TLD domain-containing protein 2, transcript variant X14
TLD domain-containing protein 2, transcript variant X13
TLD domain-containing protein 2, transcript variant X16
oxidation resistance protein 1 isoform X11
oxidation resistance protein 1 isoform X9
oxidation resistance protein 1 isoform X8
oxidation resistance protein 1 isoform X7
nuclear receptor coactivator 7 isoform X2
oxidation resistance protein 1 isoform X4
oxidation resistance protein 1 isoform X6
oxidation resistance protein 1 isoform X5
nuclear receptor coactivator 7 isoform X3
nuclear receptor coactivator 7 isoform X1
oxidation resistance protein 1 isoform X10
nuclear receptor coactivator 7 isoform X12
TLD domain-containing protein 2 isoform X13
TLD domain-containing protein 2 isoform X14
transcription factor kayak, transcript variant X2
transcription factor kayak, transcript variant X1
transcription factor kayak, transcript variant X3
ribosome-releasing factor 2, mitochondrial, transcript variant X1
ribosome-releasing factor 2, mitochondrial isoform X1
ribosome-releasing factor 2, mitochondrial, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
ribosome-releasing factor 2, mitochondrial isoform X2
28S ribosomal protein S18a, mitochondrial
D-beta-hydroxybutyrate dehydrogenase, mitochondrial
NPC intracellular cholesterol transporter 2 homolog a-like
uncharacterized LOC114876503, transcript variant X1
uncharacterized LOC114876503, transcript variant X3
uncharacterized LOC114876503, transcript variant X6
uncharacterized LOC114876503, transcript variant X2
uncharacterized protein LOC114876503 isoform X1
uncharacterized protein LOC114876503 isoform X2
sodium/potassium-transporting ATPase subunit alpha, transcript variant X3
sodium/potassium-transporting ATPase subunit alpha, transcript variant X2
sodium/potassium-transporting ATPase subunit alpha, transcript variant X1
sodium/potassium-transporting ATPase subunit alpha, transcript variant X6
sodium/potassium-transporting ATPase subunit alpha isoform X3
sodium/potassium-transporting ATPase subunit alpha isoform X2
sodium/potassium-transporting ATPase subunit alpha isoform X1
sodium/potassium-transporting ATPase subunit alpha isoform X6
uncharacterized LOC114876503, transcript variant X8
uncharacterized LOC114876503, transcript variant X9
uncharacterized LOC114876503, transcript variant X4
uncharacterized LOC114876503, transcript variant X5
uncharacterized LOC114876503, transcript variant X7
sodium/potassium-transporting ATPase subunit alpha, transcript variant X7
sodium/potassium-transporting ATPase subunit alpha, transcript variant X4
sodium/potassium-transporting ATPase subunit alpha isoform X4
sodium/potassium-transporting ATPase subunit alpha isoform X7
sodium/potassium-transporting ATPase subunit alpha, transcript variant X5
sodium/potassium-transporting ATPase subunit alpha, transcript variant X8
sodium/potassium-transporting ATPase subunit alpha isoform X5
sodium/potassium-transporting ATPase subunit alpha isoform X8
ribosomal RNA processing protein 36 homolog
DNA-directed RNA polymerases I, II, and III subunit RPABC3, transcript variant X2
DNA-directed RNA polymerases I, II, and III subunit RPABC3, transcript variant X3
DNA-directed RNA polymerases I, II, and III subunit RPABC3, transcript variant X1
DNA-directed RNA polymerases I, II, and III subunit RPABC3, transcript variant X4
DNA-directed RNA polymerases I, II, and III subunit RPABC3 isoform X1
DNA-directed RNA polymerases I, II, and III subunit RPABC3, transcript variant X5
DNA-directed RNA polymerases I, II, and III subunit RPABC3, transcript variant X6
DNA-directed RNA polymerases I, II, and III subunit RPABC3 isoform X2
uncharacterized LOC114876504, transcript variant X2
uncharacterized LOC114876504, transcript variant X3
uncharacterized LOC114876504, transcript variant X1
dynein axonemal assembly factor 10, transcript variant X1
dynein axonemal assembly factor 10 isoform X1
dynein axonemal assembly factor 10, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
dynein axonemal assembly factor 10 isoform X2
protein SEC13 homolog, transcript variant X2
protein SEC13 homolog, transcript variant X1
neurogenic locus notch homolog protein 3, transcript variant X1
neurogenic locus notch homolog protein 3, transcript variant X3
neurogenic locus notch homolog protein 3, transcript variant X2
neurogenic locus notch homolog protein 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
myosin-I heavy chain, transcript variant X2
myosin-I heavy chain, transcript variant X1
myosin-I heavy chain, transcript variant X3
kinesin-like protein Klp98A, transcript variant X1
kinesin-like protein Klp98A, transcript variant X2
ral GTPase-activating protein subunit alpha-1, transcript variant X2
ral GTPase-activating protein subunit alpha-1, transcript variant X5
ral GTPase-activating protein subunit alpha-1, transcript variant X4
ral GTPase-activating protein subunit alpha-1, transcript variant X3
ral GTPase-activating protein subunit alpha-1, transcript variant X1
ral GTPase-activating protein subunit alpha-1 isoform X2
probable Rho GTPase-activating protein CG5521 isoform X5
probable Rho GTPase-activating protein CG5521 isoform X4
probable Rho GTPase-activating protein CG5521 isoform X3
probable Rho GTPase-activating protein CG5521 isoform X1
ral GTPase-activating protein subunit alpha-1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
ral GTPase-activating protein subunit alpha-1, transcript variant X7
probable Rho GTPase-activating protein CG5521 isoform X6
probable cysteine--tRNA ligase, mitochondrial, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
probable cysteine--tRNA ligase, mitochondrial, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
probable cysteine--tRNA ligase, mitochondrial isoform X2
probable cysteine--tRNA ligase, mitochondrial isoform X1
ribosome production factor 2 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
ribosome production factor 2 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 58% coverage of the annotated genomic feature by RNAseq alignments
gametocyte-specific factor 1-like, transcript variant X2
gametocyte-specific factor 1-like, transcript variant X1
gametocyte-specific factor 1-like isoform X1
gametocyte-specific factor 1-like, transcript variant X3
gametocyte-specific factor 1-like isoform X2
proteasome subunit alpha type-4, transcript variant X2
proteasome subunit alpha type-4 isoform X2
proteasome subunit alpha type-4, transcript variant X1
proteasome subunit alpha type-4 isoform X1
7-methylguanosine phosphate-specific 5'-nucleotidase, transcript variant X2
7-methylguanosine phosphate-specific 5'-nucleotidase isoform X2
7-methylguanosine phosphate-specific 5'-nucleotidase, transcript variant X1
7-methylguanosine phosphate-specific 5'-nucleotidase, transcript variant X3
7-methylguanosine phosphate-specific 5'-nucleotidase isoform X1
7-methylguanosine phosphate-specific 5'-nucleotidase isoform X3
TP53-regulated inhibitor of apoptosis 1-like, transcript variant X1
TP53-regulated inhibitor of apoptosis 1-like isoform X1
TP53-regulated inhibitor of apoptosis 1-like, transcript variant X2
TP53-regulated inhibitor of apoptosis 1-like isoform X2
tRNA modification GTPase GTPBP3, mitochondrial, transcript variant X4
tRNA modification GTPase GTPBP3, mitochondrial, transcript variant X2
tRNA modification GTPase GTPBP3, mitochondrial, transcript variant X3
tRNA modification GTPase GTPBP3, mitochondrial, transcript variant X1
tRNA modification GTPase MnmE isoform X1
tRNA modification GTPase GTPBP3, mitochondrial isoform X2
uncharacterized protein CG4449, transcript variant X2
uncharacterized protein CG4449, transcript variant X1
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: putative nuclease HARBI1
uncharacterized LOC114880801, transcript variant X3
uncharacterized protein LOC114880801 isoform X3
uncharacterized LOC114880801, transcript variant X2
uncharacterized LOC114880801, transcript variant X1
uncharacterized protein LOC114880801 isoform X2
uncharacterized protein LOC114880801 isoform X1
39S ribosomal protein L11, mitochondrial
baculoviral IAP repeat-containing protein 6, transcript variant X1
baculoviral IAP repeat-containing protein 6, transcript variant X2
baculoviral IAP repeat-containing protein 6, transcript variant X3
baculoviral IAP repeat-containing protein 6 isoform X1
baculoviral IAP repeat-containing protein 6 isoform X2
baculoviral IAP repeat-containing protein 6 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
39S ribosomal protein L54, mitochondrial, transcript variant X1
39S ribosomal protein L54, mitochondrial, transcript variant X2
39S ribosomal protein L54, mitochondrial isoform X1
39S ribosomal protein L54, mitochondrial isoform X2
leucine-rich repeat-containing protein 49, transcript variant X1
leucine-rich repeat-containing protein 49, transcript variant X4
leucine-rich repeat-containing protein 49, transcript variant X7
leucine-rich repeat-containing protein 49, transcript variant X6
leucine-rich repeat-containing protein 49, transcript variant X2
leucine-rich repeat-containing protein 49 isoform X1
leucine-rich repeat-containing protein 49 isoform X4
leucine-rich repeat-containing protein 49 isoform X7
uncharacterized protein LOC114880802 isoform X6
leucine-rich repeat-containing protein 49 isoform X2
leucine-rich repeat-containing protein 49, transcript variant X5
leucine-rich repeat-containing protein 49, transcript variant X3
leucine-rich repeat-containing protein 49 isoform X5
leucine-rich repeat-containing protein 49 isoform X3
doublesex- and mab-3-related transcription factor 1A-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
general transcription factor 3C polypeptide 3
membrane-bound transcription factor site-1 protease, transcript variant X1
membrane-bound transcription factor site-1 protease, transcript variant X2
membrane-bound transcription factor site-1 protease, transcript variant X3
membrane-bound transcription factor site-1 protease
V-type proton ATPase subunit C, transcript variant X2
V-type proton ATPase subunit C, transcript variant X1
V-type proton ATPase subunit C isoform X2
V-type proton ATPase subunit C isoform X1
S-methyl-5'-thioadenosine phosphorylase-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 43% coverage of the annotated genomic feature by RNAseq alignments
putative uncharacterized protein DDB_G0271606
essential MCU regulator, mitochondrial, transcript variant X2
essential MCU regulator, mitochondrial, transcript variant X1
protein flightless-1, transcript variant X5
protein flightless-1, transcript variant X4
protein flightless-1, transcript variant X3
protein flightless-1, transcript variant X8
protein flightless-1, transcript variant X6
protein flightless-1, transcript variant X1
protein flightless-1, transcript variant X2
protein flightless-1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 479 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
mitochondrial import receptor subunit TOM22 homolog
golgin subfamily A member 6-like protein 6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 91% coverage of the annotated genomic feature by RNAseq alignments